期刊文献+

骨髓增生异常综合征与贫血性疾病骨髓及血细胞形态学比较分析 被引量:10

Comparative analysis of bone marrow and blood cell morphology between myelodysplastic syndrome and other anemic disease
下载PDF
导出
摘要 目的观察无或偶见原始细胞的骨髓增生异常综合征(MDS)(MDS-RA、MDS-RCMD、MDS-U)骨髓及外周血细胞形态学特点,并与其他贫血性疾病(巨幼红细胞性贫血、不发作型阵发性睡眠性血红蛋白尿)进行比较。方法抽取患者骨髓及外周血并制成涂片,行瑞氏染色后,油镜下观察分析各种细胞形态及特征。结果无或偶见原始细胞MDS的红系、粒系、巨核系病态细胞与其他贫血性疾病比较均有显著性差异(P<0.05)。结论外周血及骨髓细胞形态学检查是MDS的主要诊断方法,细胞形态学异常对于MDS与其他贫血性疾病的鉴别诊断具有重要价值,对临床治疗决策有指导意义。 objective To analysis the cellular morphological characteristics of bone marrow and peripheral blood in myelodysplastic syndrome(MDS-RA,MDS-RCMD,MDS-U) most of which had none blast cells or occasional blast cells, and to compare them with other anemic disease including megaloblastic anemia and atypical paroxysmal nocturnal hemoglubinuria (a-PNH). Methods The bone marrow and peripheral blood were collected from the patients for preparing the smears with Wright staining to study the features of different kinds of cells using microscope oil immersion lens. Results There was statistically significant difference of morbid cells of erythrocyte, granulocyte and megakaryocytic series between MDS and other anemic disease (P〈0.05). Conclusion The cell morphology of peripheral blood and bone marrow is the main diagnostic method of the MDS. The abnormality of cell morphology play an important role in differential diagnosis of MDS and other anemic disease and are helpful to the selection of the therapeutic regimen.
作者 贾红英
出处 《中国现代医生》 2014年第21期61-63,69,共4页 China Modern Doctor
关键词 骨髓增生异常综合征 细胞形态学 贫血性疾病 Myelodysplastic syndrome Cell morphology Anemia disease
  • 相关文献

参考文献11

  • 1Giagounidis A, Haase D. Morphology, cytogenetics and classification of MDS[J]. Best Pract Res Clin Haematol. 2013,26 (4):337-353.
  • 2Ma X. Epidemiology of myelodysplastic syndromes[J]. Am J Med,2012,125(7 Suppl):S2-5.
  • 3Ghariani I, Braham N, Hassine M, et al. Myelodysplastic syndrome classification[J]. Ann Biol Clin,2013,71:139- 144. G.
  • 4erming U, Strupp C, Giagounidis A. Evaluation of dys- plasia through detailed cytomorphology in 3156 patients from the dusseldorf registry on myelodysplastic syndromes[J]. Leuk Res, 2012,36:727-734.
  • 5Garcia-blanero G. blyelodysplastic syndromes: 2014 up- date on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2014,9(1 ):97-108.
  • 6刘丹丹,吴德沛.细胞形态学检查诊断骨髓增生异常综合征临床意义[J].中国实用内科杂志,2010,30(5):398-401. 被引量:20
  • 7Germing U1, Kobbe G, Haas R, et al. Myelodysplastic syndromes: diagnosis, prognosis, and treatment[J]. Dtsch Arztebl Int,2013,110(46):783-790.
  • 8胡蕊,李刚,孙洁,杨洪乐,李彦会,郭华,朱芸.病态造血质与量在骨髓增生异常综合征诊断中的重要性[J].国际检验医学杂志,2013,34(1):29-31. 被引量:8
  • 9宋现让,张炳昌.细胞病理学临床应用最新进展[M].北京:中国环境科学出版社,2008:97-105.
  • 10Glauser TA, Sagatys EM, Williamson JC, et al. Current pathology practices in and barriers to MDS diagnosis[J]. Leuk Res,2013,37 (12):1656-1661.

二级参考文献17

  • 1Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues [ M ]. Lyon, France : IARC Press ,2001:61 - 73.
  • 2Steven HS, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues [ M ]. Lyon, France : IARC press,2008 : 88 - 99.
  • 3Liu DD, Chen ZX, Xue YQ, et al. The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients [ J ]. Leuk Res, 2009,33 : 1029 - 1038.
  • 4Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes : Consensus statements and report from a working conference [ J ]. Leuk Res,2007,31:727 -736.
  • 5Mufti GJ, Bennett JM, Goasguen J, et al. Diagnosis and classification of myelodysplastic syndrome : International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts[ J]. Haematologica ,2008,93 : 1712 - 1717.
  • 6Goasguen JE, Bennett JM, Bain B, et al. Large field virtual microscopy as a tool for quality control and blast definitions in MDS and leukemia. From the International Working Group on MDS [ J ]. Blood ( ASH Annual Meeting Abstracts ) ,2006,108 : 2616.
  • 7代荣琴,张金彪,李吉勇.骨髄增生异常综合征的实验室诊断[J].临床血液学杂志:输血与检验版,2009,22(10) :567-569.
  • 8Dayyani F,Conley AP,Strom SS,et al. Cause of death in patientswith lower-risk myelodysplastic syndrome [J]. Cancer,2010, 116(9):2174-2179.
  • 9Verburgh E, Achten R,Louwv J,et al. A new disease categoriza-tion of low grade myelodysplastic syndromes based on the expres-sion of cytopenia and dysplasia in one versus more than one line-age improves on the WHO classification[J]. Leukemia, 2007, 21(5):668-677.
  • 10Garcia-Manero G, Shan J, Faderl S,et al. A prognostic score forpatients with lower risk myelodysplastic syndromeCJl. Leukemia,2008,22(4):538-543.

共引文献26

同被引文献68

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部